Who Buys Pembrolizumab from India — 66 Importers Behind a $1.9M Market
India's pembrolizumab import market is served by 66 active buyers who collectively imported $1.9M across 215 shipments. INDIRA GANDHI MEMORIAL HOSPITAL (MALDIVES) leads with a 6.7% market share, followed by AS PER INVOICE and MERMISI LLC. The top 5 buyers together control 20.6% of total import value, reflecting a moderately competitive buyer landscape.
Pembrolizumab buyer data — 66 importers · $1.9M market · 215 shipmentsTransData Nexus · Indian Customs Data
Top Pembrolizumab Importers — Ranked by Import Value
INDIRA GANDHI MEMORIAL HOSPITAL (MALDIVES) is the leading pembrolizumab importer from India, holding a 6.7% share of the $1.9M market across 215 shipments from 66 buyers. The top 5 buyers — INDIRA GANDHI MEMORIAL HOSPITAL (MALDIVES), AS PER INVOICE (BRAZIL), MERMISI LLC (GEORGIA), KARLENE SMALL (JAMAICA), F AGAINST PROFORMA INVOICE (BRAZIL) — collectively control 20.6% of total import value.
Top Pembrolizumab Buyers & Importers
Ranked by import value · 66 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Pembrolizumab Buyers & Importers — Ranked by Import Value. 66 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Pembrolizumab — and from which countries?
Flow of Pembrolizumab exports from India: each country's share and the named importers behind the numbers
Pembrolizumab — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 77.6% of global Pembrolizumab imports — led by Brazil (44.6%) with a total trade value of $1.9M across 215 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil emerges as the first largest importing country, achieving a total trade value of $860.1K through 41 shipments. This represents a market share of 44.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• AS PER INVOICE - $105.6K (12.3% of country's total business)
• F AGAINST PROFORMA INVOICE - $48.9K (5.7% of country's total business)
• RICARDO LUIZ BARBOZA - $47.4K (5.5% of country's total business)
• ERINEA FERRAZ DOS - $47.2K (5.5% of country's total business)
• EXP CODE - $29.5K (3.4% of country's total business)
• Rest of Brazil's importers - $581.5K (67.6% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $21.0K, indicating premium pricing strategy compared to the market average of $9.0K.
Brazil is a key market for Pembrolizumab imports, representing 44.6% of total trade value.
The importation of Pembrolizumab from India involves various buyer segments, each with distinct purchasing behaviors:
Hospital Groups: Entities like the Indira Gandhi Memorial Hospital in the Maldives ($0.13M) fall into this category. These institutions procure Pembrolizumab directly to administer to patients within their facilities, often placing large, periodic orders to meet patient demand.
Individual Buyers: Names such as Karlene Small ($0.05M) and Keisha Young-Henry ($0.05M) from Jamaica suggest individual purchasers, possibly patients or their representatives, importing the drug for personal use. Their buying patterns are typically characterized by smaller, irregular orders based on personal treatment schedules.
Distributors: Entities like MERMISI LLC in Georgia ($0.06M) likely serve as intermediaries, purchasing Pembrolizumab in bulk to supply to healthcare providers or pharmacies. Distributors usually place consistent, sizable orders to maintain inventory levels and meet market demand.
Re-exporters: Buyers listed as "AS PER INVOICE" ($0.11M) and "F AGAINST PROFORMA INVOICE" ($0.05M) in Brazil may represent re-exporters. These entities import Pembrolizumab with the intent to export it to other markets, often capitalizing on price differentials or regulatory environments. Their purchasing behavior can be opportunistic, influenced by market conditions and demand in target export destinations.
Importing Pembrolizumab into the top five importing countries involves navigating specific regulatory frameworks:
Brazil:
Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
Import Registration Process: ANVISA requires a comprehensive dossier, including clinical data and manufacturing details, for drug registration.
Estimated Timeline: The process can take approximately 12 to 24 months, depending on the completeness of the application and ANVISA's workload.
Import Tariff/Duty: Pharmaceutical products under HS Code 30021500 are subject to a standard import duty of 8%, with additional taxes such as the Industrialized Product Tax (IPI) and the Merchandise and Service Circulation Tax (ICMS) varying by state.
The demand for Pembrolizumab across importing countries is influenced by several factors:
Disease Prevalence: Rising incidences of cancers, particularly those treatable with Pembrolizumab, such as non-small cell lung cancer and melanoma, drive demand. For instance, Brazil has seen an increase in cancer cases, necessitating advanced therapeutic options.
Government Healthcare Programs: Initiatives aimed at improving cancer care, including funding for advanced treatments, bolster demand. Countries like Brazil and Jamaica have national cancer control programs that facilitate access to immunotherapies.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased access to essential medicines. The Maldives, for example, has expanded healthcare services, ensuring broader access to treatments like Pembrolizumab.
WHO Essential Medicines List Procurement: Inclusion of cancer therapies in national essential medicines lists, guided by WHO recommendations, prompts procurement by public health systems.
Common Questions — Pembrolizumab Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest pembrolizumab buyer importing from India?
Based on import volume and value, INDIRA GANDHI MEMORIAL HOSPITAL (MALDIVES) leads with $130.1K in imports and a 6.7% market share — the highest of any single pembrolizumab importer. AS PER INVOICE (BRAZIL) and MERMISI LLC (GEORGIA) are the next largest buyers.
QHow many companies buy pembrolizumab from India?
There are 66 active pembrolizumab buyers importing from India, with a combined market of $1.9M across 215 shipments to 21 countries. The top 5 buyers hold 20.6% of total import value, while the remaining 61 buyers handle the other 79.4%.
QWhich countries import the most pembrolizumab from India?
The top importing countries for pembrolizumab from India are Brazil (44.6%), Zimbabwe (8.5%), Maldives (8.4%), Jamaica (8.4%), Georgia (7.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of pembrolizumab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for pembrolizumab from India?
The average import transaction value for pembrolizumab from India is $9.0K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Pembrolizumab from India involves various buyer segments, each with distinct purchasing behaviors:
Hospital Groups: Entities like the Indira Gandhi Memorial Hospital in the Maldives ($0.13M) fall into this category. These institutions procure Pembrolizumab directly to administer to patients within their facilities, often placing large, periodic orders to meet patient demand.
Individual Buyers: Names such as Karlene Small ($0.05M) and Keisha Young-Henry ($0.05M) from Jamaica suggest individual purchasers, possibly patients or their representatives, importing the drug for personal use. Their buying patterns are typically characterized by smaller, irregular orders based on personal treatment schedules.
Distributors: Entities like MERMISI LLC in Georgia ($0.06M) likely serve as intermediaries, purchasing Pembrolizumab in bulk to supply to healthcare providers or pharmacies. Distributors usually place consistent, sizable orders to maintain inventory levels and meet market demand.
Re-exporters: Buyers listed as "AS PER INVOICE" ($0.11M) and "F AGAINST PROFORMA INVOICE" ($0.05M) in Brazil may represent re-exporters. These entities import Pembrolizumab with the intent to export it to other markets, often capitalizing on price differentials or regulatory environments. Their purchasing behavior can be opportunistic, influenced by market conditions and demand in target export destinations.
Importing Pembrolizumab into the top five importing countries involves navigating specific regulatory frameworks:
Brazil:
Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
Import Registration Process: ANVISA requires a comprehensive dossier, including clinical data and manufacturing details, for drug registration.
Estimated Timeline: The process can take approximately 12 to 24 months, depending on the completeness of the application and ANVISA's workload.
Import Tariff/Duty: Pharmaceutical products under HS Code 30021500 are subject to a standard import duty of 8%, with additional taxes such as the Industrialized Product Tax (IPI) and the Merchandise and Service Circulation Tax (ICMS) varying by state.
The demand for Pembrolizumab across importing countries is influenced by several factors:
Disease Prevalence: Rising incidences of cancers, particularly those treatable with Pembrolizumab, such as non-small cell lung cancer and melanoma, drive demand. For instance, Brazil has seen an increase in cancer cases, necessitating advanced therapeutic options.
Government Healthcare Programs: Initiatives aimed at improving cancer care, including funding for advanced treatments, bolster demand. Countries like Brazil and Jamaica have national cancer control programs that facilitate access to immunotherapies.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage lead to increased access to essential medicines. The Maldives, for example, has expanded healthcare services, ensuring broader access to treatments like Pembrolizumab.
WHO Essential Medicines List Procurement: Inclusion of cancer therapies in national essential medicines lists, guided by WHO recommendations, prompts procurement by public health systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
2Zimbabwe
Zimbabwe emerges as the second largest importing country, achieving a total trade value of $163.5K through 0 shipments. This represents a market share of 8.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Zimbabwe demonstrates strong market positioning with an average shipment value of $163.5K, indicating premium pricing strategy compared to the market average of $9.0K.
Zimbabwe is a key market for Pembrolizumab imports, representing 8.5% of total trade value.
Primary Market
Secondary Market
3Maldives
Maldives emerges as the third largest importing country, achieving a total trade value of $161.9K through 30 shipments. This represents a market share of 8.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Maldives has a diverse importer base, with their top importers including:
• INDIRA GANDHI MEMORIAL HOSPITAL - $130.1K (80.4% of country's total business)
Key Insight: Maldives demonstrates strong market positioning with an average shipment value of $5.4K, indicating competitive pricing strategy compared to the market average of $9.0K.
Maldives is a key market for Pembrolizumab imports, representing 8.4% of total trade value.
Primary Market
Secondary Market
4Jamaica
Jamaica emerges as the fourth largest importing country, achieving a total trade value of $161.5K through 4 shipments. This represents a market share of 8.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Jamaica has a diverse importer base, with their top importers including:
• KARLENE SMALL - $53.3K (33.0% of country's total business)
• KEISHA YOUNG-HENRY - $47.8K (29.6% of country's total business)
Key Insight: Jamaica demonstrates strong market positioning with an average shipment value of $40.4K, indicating premium pricing strategy compared to the market average of $9.0K.
Jamaica is a key market for Pembrolizumab imports, representing 8.4% of total trade value.
Primary Market
Secondary Market
5Georgia
Georgia emerges as the fifth largest importing country, achieving a total trade value of $150.4K through 6 shipments. This represents a market share of 7.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Georgia has a diverse importer base, with their top importers including:
• MERMISI LLC - $59.9K (39.8% of country's total business)
Key Insight: Georgia demonstrates strong market positioning with an average shipment value of $25.1K, indicating premium pricing strategy compared to the market average of $9.0K.
Georgia is a key market for Pembrolizumab imports, representing 7.8% of total trade value.
Primary Market
Secondary Market
Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring compliance with regulatory requirements in diverse markets.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Medicines Control Authority of Zimbabwe (MCAZ).
Import Registration Process: MCAZ mandates submission of an application with supporting documents, including quality, safety, and efficacy data.
Estimated Timeline: The registration process typically spans 6 to 12 months.
Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties to promote access to essential medicines.
Maldives:
Regulatory Authority: Maldives Food and Drug Authority (MFDA).
Import Registration Process: Importers must obtain an import license from the MFDA, providing product details and manufacturer information.
Estimated Timeline: The approval process usually takes 1 to 3 months.
Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties to ensure affordable healthcare.
Jamaica:
Regulatory Authority: Pharmacy Council of Jamaica.
Import Registration Process: Importers must register the drug with the Pharmacy Council, submitting necessary documentation for evaluation.
Estimated Timeline: The registration process can take 6 to 9 months.
Import Tariff/Duty: Pharmaceuticals are generally subject to a 5% import duty, with possible exemptions for essential medicines.
Georgia:
Regulatory Authority: State Regulation Agency for Medical Activities.
Import Registration Process: Requires submission of an application with comprehensive product information and compliance with local standards.
Estimated Timeline: The process typically takes 6 to 12 months.
Import Tariff/Duty: Pharmaceuticals are usually exempt from import duties to facilitate access to healthcare products.
Navigating these regulatory landscapes is essential for successful market entry and sustained distribution of Pembrolizumab in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government tenders for pharmaceuticals create opportunities for suppliers. Zimbabwe and Georgia often utilize tender systems to procure medicines, including oncology drugs.
With 66 buyers across 21 countries, the market for Pembrolizumab imported from India reflects a growing global need for effective cancer treatments, presenting significant opportunities for suppliers attuned to these demand drivers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$1743.00 per unit
Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring compliance with regulatory requirements in diverse markets.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Medicines Control Authority of Zimbabwe (MCAZ).
Import Registration Process: MCAZ mandates submission of an application with supporting documents, including quality, safety, and efficacy data.
Estimated Timeline: The registration process typically spans 6 to 12 months.
Import Tariff/Duty: Pharmaceuticals are generally exempt from import duties to promote access to essential medicines.
Maldives:
Regulatory Authority: Maldives Food and Drug Authority (MFDA).
Import Registration Process: Importers must obtain an import license from the MFDA, providing product details and manufacturer information.
Estimated Timeline: The approval process usually takes 1 to 3 months.
Import Tariff/Duty: Pharmaceuticals are typically exempt from import duties to ensure affordable healthcare.
Jamaica:
Regulatory Authority: Pharmacy Council of Jamaica.
Import Registration Process: Importers must register the drug with the Pharmacy Council, submitting necessary documentation for evaluation.
Estimated Timeline: The registration process can take 6 to 9 months.
Import Tariff/Duty: Pharmaceuticals are generally subject to a 5% import duty, with possible exemptions for essential medicines.
Georgia:
Regulatory Authority: State Regulation Agency for Medical Activities.
Import Registration Process: Requires submission of an application with comprehensive product information and compliance with local standards.
Estimated Timeline: The process typically takes 6 to 12 months.
Import Tariff/Duty: Pharmaceuticals are usually exempt from import duties to facilitate access to healthcare products.
Navigating these regulatory landscapes is essential for successful market entry and sustained distribution of Pembrolizumab in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Government tenders for pharmaceuticals create opportunities for suppliers. Zimbabwe and Georgia often utilize tender systems to procure medicines, including oncology drugs.
With 66 buyers across 21 countries, the market for Pembrolizumab imported from India reflects a growing global need for effective cancer treatments, presenting significant opportunities for suppliers attuned to these demand drivers.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 66 global importers of Pembrolizumab identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 215 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 21 destination countries with market share per buyer calculated from capped values.
